This site is intended for Healthcare Professionals only
Back to CKS

Preventative medicine Infections and infestations

Healthcare-associated infections

Last revised in June 2024

A healthcare-associated infection develops as a direct result of healthcare interventions, e.g. medical, surgical treatment, or direct contact with a healthcare setting.

Healthcare-associated infections: Summary

  • A healthcare-associated infection is a problem which develops as a direct result of healthcare interventions for example, medical or surgical treatment, or as a result of direct contact with a healthcare setting.
  • Healthcare-associated infections are caused by a wide range of microorganisms, which have gained entry into the body by an invasive device or procedure, including: 
    • Meticillin-resistant Staphylococcus aureus (MRSA).
    • Meticillin-sensitive Staphylococcus aureus (MSSA).
    • Clostridioides difficile (C. difficile). 
    • Escherichia coli (E. coli).
  • Around 300,000 people a year in England acquire a healthcare-associated infection as a result of NHS care.
  • The most common types are respiratory infections (including pneumonia and infections of the lower respiratory tract; 22.8%), urinary tract infections (17.2%) and surgical site infections (15.7%).
  • They are transmitted via blood, body fluids or excretions, and can result from:
    • Contact with non-intact skin or mucous membranes, and any equipment or items in the care environment that could have become contaminated.
    • Inhalation of droplets or airborne infections. 
    • Inoculation incidents.
  • Healthcare-associated infections can exacerbate existing or underlying conditions, delay recovery and adversely affect quality of life. 
  • Standard infection control precautions are the basic minimum standard of hygiene to be applied throughout all contact with blood and body fluids from any source to control the spread of infection within clinical practice and should comprise: 
    • Assessment of the risk to and from individuals.
    • Hand hygiene measures. 
    • Appropriate use of personal protective equipment.  
    • Respiratory and cough hygiene.  
    • Safe management of equipment 
    • Maintenance of environmental cleanliness.   
    • Safe management of laundry, and blood and body fluid spillages.  
    • Safe disposal of waste and sharps. 
  • All people involved in providing care should be:
    • Educated about the standard principles of infection prevention and control.
    • Trained in hand decontamination, the use of personal protective equipment and the safe use and disposal of sharps.   
  • Additional precautions should be used when inserting and managing invasive devices, including:
    • Ensuring all equipment is sterile, packaging is intact and within the expiry date.
    • Performing skin decontamination prior to inserting a device through the skin (for example using 2% Chlorhexidine in 70% alcohol).
    • Maintaining a ‘closed’ system with as few connections as possible to reduce the risk of contamination.
    • Applying standard precautions and aseptic technique when manipulating the device.
  • Additional transmission based precautions may be necessary for people with a known/suspected infectious agent, including:
    • Scheduling people to attend for a procedure at the end of the session to allow for environmental cleaning.
    • Wearing disposable gloves and apron when in contact with body fluids and disposing of these after each procedure.
    • Wearing long sleeved fluid repellent gowns if there is a risk of extensive splashing of body fluids.
    • Cleaning the treatment couch and immediate area with detergent and warm water followed by a hypochlorite solution or a disinfectant wipe.
    • Disposing of waste contaminated with body fluids as infectious waste.

Have I got the right topic?

From birth onwards.

This CKS topic covers the prevention and control of healthcare-associated infections in primary care.

This CKS topic does not cover the prevention and control of healthcare-associated infections in other care settings, including care homes or secondary care, or outbreaks of communicable diseases, or the management of diagnosed healthcare-associated infections.

There are separate CKS topics on Diarrhoea - antibiotic associated, Gastroenteritis, Hepatitis B, Hepatitis C, HIV infection and AIDS, MRSA in primary care, Urinary tract infection (lower) - men, and Urinary tract infection (lower) - women. 

The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.

How up-to-date is this topic?

Changes

June 2024 — Reviewed. A literature search was conducted in June 2024 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. 

Previous changes

July 2023 — minor update. The information regarding disposal of sharps boxes after 3 months, whether they are full or not, has been removed from this recommendation to align with an update to NICE guidance Healthcare-associated infections: prevention and control in primary and community care [CG139].

May 2019 — new topic. A literature search was conducted in April 2019 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.

Update

New evidence

Evidence-based guidelines

No new evidence-based guidelines since 1 June 2024.

HTAs (Health Technology Assessments)

No new HTAs since 1 June 2024.

Economic Appraisals

No new economic appraisals relevant to England since 1 June 2024.

Systematic reviews and meta-analyses

No new systematic reviews or meta-analysis which reach the CKS threshold for inclusion since 1 June 2024.

Primary evidence

No new primary evidence which reaches the CKS threshold for inclusion published since 1 June 2024.

New policies

No new national policies or guidelines since 1 June 2024.

New safety alerts

No new safety alerts since 1 June 2024.

Changes in product availability

No changes in product availability since 1 June 2024.

Goals and outcome measures

Goals

To support primary healthcare professionals to:

  • Assess the risk of healthcare-associated infections.
  • Understand and apply standard infection control precautions to reduce the transmission of healthcare-associated infections.
  • Understand and apply the additional infection control precautions required when using invasive devices.
  • Understand and apply the transmission based precautions required for specific infections.

Outcome measures

No outcome measures were found during the review of this topic.

Audit criteria

No audit criteria were found during the review of this topic.

QOF indicators

No QOF indicators were found during the review of this topic.

QIPP - Options for local implementation

No QIPP indicators were found during the review of this topic.

NICE quality standards

Infection prevention and control

  • People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.
  • Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.
  • People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.
  • People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.
  • People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.
  • People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection.

[NICE, 2022]

Background information

What is it?

  • A healthcare-associated infection is an infection that develops as a result of contact with healthcare settings or medical intervention. This includes infections contracted:
    • As a direct result of medical or surgical treatment in, or contact with, a health or social care setting. 
    • As a result of healthcare delivered in the community.
    • Outside of a healthcare setting and brought in by people undergoing treatment, staff, or visitors.

[NICE, 2023] 

What causes it?

  • Healthcare-associated infections are caused by a wide range of microorganisms (often carried by the people themselves) that have gained entry into the body by an invasive device or procedure, the most common being:
    • Meticillin-resistant Staphylococcus aureus (MRSA).
    • Meticillin-sensitive Staphylococcus aureus (MSSA).
    • Clostridiodes difficile (C. difficile). 
    • Escherichia coli (E. coli).
  • Sources of (potential) infection include blood and other body fluids, secretions or excretions (excluding sweat), non-intact skin or mucous membranes, and any equipment or items in the care environment that could have become contaminated. Transmission can occur as a result of:
    • Contact with non-intact skin or mucous membranes and any equipment or items in the care environment that could have become contaminated.
    • Inhalation of droplets (for example, from the respiratory tract of one individual directly onto a mucosal surface or conjunctivae of another) or airborne infections.
    • Inoculation incidents such as: 
      • A percutaneous injury, for example, injuries from needles, instruments, bone fragments, or bites that break the skin.
      • Exposure of broken skin, for example, abrasions, cuts, and eczema.
      • Exposure of mucous membranes, including the eye, from splashing of blood or other high-risk body fluids.

[NICE, 2017; NICE, 2023; NHS England, 2024]

How common is it?

  • Healthcare-associated infections (HCAIs) occur across a wide range of clinical conditions and can affect people of all ages.
    • Healthcare workers, family members and carers are also at risk of acquiring infections.
  • It is estimated that 300,000 people a year in England acquire an HCAI as a result of NHS care. however, recent modelling data suggests that in 2016/2017:
    • There were 653,000 HCAIs among inpatients in NHS general and teaching hospitals, with an additional 13,900 HCAIs among front-line healthcare providers, resulting in 22,800 deaths.
    • HCAIs were estimated to cost the NHS £2.7 billion, which was almost entirely attributed to costs associated with patient management.
  • The most common types of healthcare-associated infections are respiratory infections (including pneumonia and infections of the lower respiratory tract; 22.8%), urinary tract infections (17.2%), surgical site infections (15.7%), sepsis (10.5%), gastrointestinal infections (8.8%), and bloodstream infections (7.3%). 

[NICE, 2017; Guest, 2020; NICE, 2022]

What are the risk factors for healthcare-associated infections?

  • Healthcare-associated infections can occur in otherwise healthy individuals, especially if invasive procedures or devices are used. 
    • Indwelling urinary catheters are the most common cause of urinary tract infections.
    • Bloodstream infections are associated with vascular access devices.
  • Susceptibility to healthcare-associated infection depends on a number of factors, including: 
    • Genetic or constitutional factors.
    • Specific immunity.
    • Non-specific factors — malnutrition, alcoholism, or the presence of a disease or treatment that impairs the nonspecific immune response. 
  • Independent factors which predict 30-day mortality from E. coli bloodstream infection (BSI) include: 
    • Age — people aged under 1 year or over 44 years carry a 3-fold risk, while in people aged over 85 years there is a 6-fold increase.
    • Respiratory focus of E. coli infection, or where an underlying focus is unknown.
    • Hospital-onset infection, but also: 
      • People with E. coli BSI who are not admitted to hospital.
      • E. coli bacteraemia that is not susceptible to ciprofloxacin.
    • Winter onset.
    • Male gender.
  • For risk factors associated with C. difficile infection see the risk factors section in the CKS topic Diarrhoea - antibiotic associated
  • Risk factors associated with acquiring meticillin-resistant Staphylococcus aureus (MRSA):
    • Underlying illness.
    • Older age — particularly if they have a chronic illness.
    • The very ill — for example, people in intensive care units.
    • Open wounds or people who have had major surgery.
    • People with invasive devices such as urinary catheters.
  • Risk factors associated with acquiring Panton-Valentine Leukocidin Staphylococcus aureus (PVL-SA) include: 
    • Younger age. 
    • Contaminated shared items (for example, towels).
    • Close contact, including contact sports (for example, wrestling, rugby, and judo).
    • Crowding (for example, closed communities and military training camps).
    • Cleanliness.
    • Cuts and other compromised skin integrity, chronic skin conditions (for example, eczema and psoriasis).

[NICE, 2017; PHE, 2017; IPC, 2023a; IPC, 2023b]

What is the prognosis?

  • Healthcare-associated infections can exacerbate existing or underlying conditions, delay recovery and adversely affect quality of life. 
    • The impact can range from superficial to life-threatening and include social, psychological and physical effects. 
    • People may suffer pain, require additional interventions, or experience extended length of stay and long-term physical effects as a result of infection. 

[NICE, 2017; RCN, 2017; IPC, 2023c]

Management

Scenario: Prevention and control of healthcare associated infections

From birth onwards.

How should I assess the risk of healthcare-associated infections?

  • Assess the risk to and from individuals promptly on arrival at the care area — this assessment should influence referral decisions in accordance with clinical need. 
    • Take into account the task, the level of interaction and/or the anticipated level of exposure to blood and/or other body fluids. 
    • Identify the steps that need to be taken to reduce or control the risks. 
    • Ensure methods and interventions in place to monitor the risks of infection to determine whether further steps are needed to reduce or control infection. 
  • Standard infection control procedures may be insufficient to prevent cross transmission of specific infections.
    • Additional transmission based precautions (TBPs) may be necessary depending on clinical judgement. This should be based on the: 
      • Suspected/known infectious agent.
      • Severity of the illness caused.
      • Transmission route of the infectious agent.
      • Care setting and procedures undertaken.
  • People who may present a cross-infection risk include those:
    • With diarrhoea, vomiting, an unexplained rash, fever or respiratory symptoms.
    • Known to have been previously positive with a multi-drug resistant organism (MDRO), for example, meticillin-resistant Staphylococcus aureus (MRSA).
    • Who have been an inpatient in any hospital in the UK or abroad in the last 12 months.
    • Who have been close contact with a person who has been colonised or infected with carbapenemase-producing Enterobacterales in the last 12 months.
  • Prioritise people with suspected/known infection/colonisation for assessment/treatment (for example, scheduled appointments at the start or end of the clinic session). Infectious people should be separated from others while awaiting assessment and during care management by at least one metre.
  • If an emergency referral to hospital is required, the ambulance service should be informed of the infectious status of the patient.

Basis for recommendation

These recommendations are based on the NHS National Services Scotland (NHS NSS) guidance National infection prevention and control manual  [NHS NSS, 2024], The Health and Social Care Act 2008: code of practice on the prevention and control of infections [DHSC, 2022], and the NHS England policy document NHS England National infection prevention and control manual (NIPCM) for England [NHS England, 2024]. 

What standard infection control precautions should I take to reduce the risk of healthcare-associated infections?

  • All primary care medical practices must comply with the Health and Social Care Act 2008: Code of Practice for the Prevention and control of healthcare-associated infections, and Care Quality Commission (CQC) registration requirements. 
  • Standard infection control precautions are the basic minimum standard of hygiene to be applied throughout all contact with blood and body fluids from any source to control the spread of infection within clinical practice. 
  • Standard infection control precautions comprise the following elements: 
  • Ensure all people involved in providing care are:
  • Ensure appropriate supplies are available of: 
    • Materials for hand decontamination.
    • Sharps containers.
    • Personal protective equipment.
  • Educate people and their carers about: 
    • The benefits of effective hand decontamination. 
    • The correct techniques and timing of hand decontamination.
    • When it is appropriate to use liquid soap and water or hand rub.
    • The availability of hand decontamination facilities.
    • Their role in maintaining standards of healthcare workers' hand decontamination.
    • Respiratory and cough hygiene. 

Table 1. Health and Social Care Act 2008: code of practice for the prevention and control of healthcare-associated infections

Compliance criterionWhat needs to be demonstrated
1

Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider the susceptibility of service users and any risks that their environment and other users may pose to them.

2

Provide and maintain a clean and appropriate environment in managed premises that facilitates the prevention and control of infections.

3

Ensure appropriate antimicrobial use to optimise patient outcomes and to reduce the risk of adverse events and antimicrobial resistance.

4

Provide suitable accurate information on infections to service users, their visitors and any person concerned with providing further support or nursing/ medical care in a timely fashion.

5

Ensure prompt identification of people who have or are at risk of developing an infection so that they receive timely and appropriate treatment to reduce the risk of transmitting infection to other people.

6

Systems to ensure that all care workers (including contractors and volunteers) are aware of and discharge their responsibilities in the process of preventing and controlling infection.

7

Provide or secure adequate isolation facilities.

8

Secure adequate access to laboratory support as appropriate.

9

Have and adhere to policies, designed for the individual’s care and provider organisations that will help to prevent and control infections.

10

Providers have a system in place to manage the occupational health needs and obligations of staff in relation to infection.

Source: [DHSC, 2022]

Hand hygiene

  • Decontaminate hands immediately:
    • Immediately Before every episode of direct contact with a person or care, including aseptic procedures.
    • Immediately after every episode of direct contact with a person or care
    • Immediately after any exposure to body fluids, mucous membranes, non-intact skin, or wound dressings.
    • Immediately after any other activity or contact with a person's surroundings that could potentially result in hands becoming contaminated.
    • Immediately before putting on, and immediately after the removal of, gloves.
  • Also decontaminate hands: 
    • Before handling an invasive device, regardless of whether gloves are used or not.
    • If moving from a contaminated body site to another body site during the care of the same person.
  • Decontaminate hands preferably with a hand rub conforming to current British standards, except in the following circumstances when liquid soap and water must be used: 
    • When hands are visibly soiled or potentially contaminated with body fluids.
    • When caring for patients with vomiting or diarrhoeal disease.
    • In clinical situations where there is potential for the spread of alcohol-resistant organisms (such as Clostridiodes difficile or other organisms that cause diarrhoeal illness).
      • Antimicrobial hand wipes are permitted where there is no access to running water. Hand hygiene using a hand rub must be performed immediately after use of antimicrobial hand wipes, and hand hygiene using soap and water must be performed as soon as possible.
  • Ensure hands can be decontaminated throughout the duration of clinical work: 
    • Keep arms bare below the elbow when delivering direct care. This includes wearing short-sleeved garments or being able to roll up the sleeves.
    • Remove wrist and hand jewellery.
    • Make sure that fingernails are short, clean and free of nail polish. 
    • Cover cuts and abrasions with waterproof dressings.
  • Use paper towels in clinical areas and staff toilets — good quality soft paper towels will help to prevent skin abrasion.
    • Do not use fabric hand towels.
  • Do not routinely use nail brushes.
    • Nail picks (single-use) may be used prior to some invasive procedures if the nails are visably dirty.
  • An effective handwashing technique involves three stages: preparation, washing and rinsing, and drying.
    • Wet the hands under tepid running water (avoid using hot water, as repeated exposure to hot water may increase the risk of dermatitis) before applying liquid soap or an antimicrobial preparation.
    • Ensure the handwash solution comes into contact with all of the surfaces of the hand. Rub the hands together vigorously for a minimum of 10–15 seconds, and pay particular attention to the tips of the fingers, the thumbs and the areas between the fingers.
    • Rinse hands thoroughly, then dry with good quality paper towels.
  • When Decontaminating hands using an alcohol handrub:  
    • Ensure hands are free from dirt and organic material.
    • Ensure the handrub solution comes into contact with all surfaces of the hand. Rub the hands together vigorously, paying particular attention to the tips of the fingers, the thumbs and the areas between the fingers, until the solution has evaporated and the hands are dry.
  • Apply an emollient hand cream regularly to protect skin from the drying effects of regular hand decontamination. If a particular soap, antimicrobial hand wash, or alcohol product causes skin irritation, an occupational health team should be consulted. 

Personal protective equipment

  • Base the selection of personal protective equipment (PPE) on the risk of: 
    • Transmission of the microorganism(s).
    • Contamination of clothing and skin by blood, body fluids, secretions or excretions.
  • All PPE must be:
    • Located close to the point of use.
    • Stored to prevent contamination in a clean, dry area until required.
    • Single-use only unless specified by the manufacturer.
    • Changed immediately after each patient and/or after completing a procedure or task.
    • Disposed of after use in the appropriate waste stream or, in the case of reusable PPE such as face shields, decontaminated after each use according to the manufacturer's specifications. 
    • Discarded if damaged, contaminated, or past the expiry date.
  • Equipment that may be appropriate to use includes:
    • Gloves. These must be:
      • Worn for invasive procedures, contact with sterile sites and non-intact skin or mucous membranes, and all activities that have been assessed as carrying a risk of exposure to blood, body fluids, secretions or excretions, or to sharp or contaminated instruments. The use of gloves does not replace the need for hand hygiene measures.  
      • Worn as single-use items and changed between caring for different people and between different care or treatment activities for the same person.
      • Put on immediately before an episode of contact or treatment and removed as soon as the activity is completed. They must then be disposed of correctly, in accordance with current national legislation or local policies.
      • Changed if they are damaged or damage is suspected, for example, puncture or perforation. 
      • Be appropriate for the task and well-fitting.
      • Conform to current EU legislation (CE marked as medical gloves for single use). Alternatives to natural rubber latex gloves must be available for people who have a documented sensitivity to natural rubber latex. Do not use polythene gloves for clinical interventions.
    • Disposable plastic aprons or gowns. These must be:
      • Worn if there is a risk that clothing may be exposed to blood, body fluids, secretions, or excretions. Wear a long-sleeved fluid-repellent gown if there is a risk of extensive splashing of blood, body fluids, secretions, or excretions onto skin or clothing, or an apron provides inadequate cover for the procedure or task being performed.
      • Worn as single-use items for one procedure or one episode of direct care. They must be disposed of correctly in accordance with current national legislation or local policies.
    • Face masks and eye protection. These must be:
      • Worn if there is a risk of blood, body fluids, secretions, or excretions splashing into the face and eyes. Regular corrective spectacles are not considered eye protection.
      • Not impeded by accessories such as false eyelashes or piercings.
      • Not be touched when being worn.

Safe use and disposal of sharps

  • Sharps include needles, cannulas, stitch cutters, scalpels, razor blades, broken glass, and medical instruments (for example, scissors and other sharp objects). 
  • Train and assess all users in good practice in sharps management — this should cover the correct use and disposal of sharps and sharps safety devices, and what to do in the event of an injury.
    • Do not pass sharps directly from hand to hand — keep handling to a minimum. 
    • Do not bend or break used standard needles before disposal, and do not recap needles. 
    • If a safety device is being used, safety mechanisms should be deployed before disposal. 
    • The person generating the sharps waste should discard used sharps immediately (dispose of the needle and syringe as one unit) into the correct colour-coded sharps container, which must conform to current standards. Best practice colour coding is as follows:
      • Purple lid — cytostatic or cytotoxic medicines.
      • Orange lid — not contaminated with medicines.
      • Yellow lid  — contaminated with medicines. 
    • Sharps containers:
      • Must be located in a safe position (not on the floor) that avoids spillage, at a height that allows the safe disposal of sharps, and is away from public access areas and out of the reach of children.
      • Must not be used for any other purpose than the disposal of sharps.
      • Must not be filled above the fill line.
      • Must be disposed of when the fill line is reached and labelled with the date, source prior to disposal and a signature when assembled, locked and disposed of. 
      • Should be temporarily closed when not in use.
    • Use sharps safety devices if a risk assessment has indicated that they will provide safer systems of working for healthcare workers, carers, and patients.

Venepuncture

  • Prior to the venepuncture procedure: 
    • Wash hands with liquid soap and warm running water or use alcohol hand rub using the Hand decontamination technique. 
    • Put on disposable apron.
    • Decontaminate hands again after applying the tourniquet and palpating the vein.
    • Put on disposable gloves.
    • Clean the person's skin with 70% isopropyl alcohol skin wipes for 30 seconds and allow the skin to dry.
  • Once the venepuncture procedure is complete:
    • Release the tourniquet and place a low-linting sterile gauze over the puncture site.
    • Once the needle is removed, discard sharps in a sharps container.
    • Apply pressure and use an additional piece of sterile gauze if necessary. 
    • Inspect the puncture point for bleeding.
    • Apply a sterile adhesive plaster or hypoallergenic tape.
    • Remove and dispose of gloves and apron.
    • Wash hands with liquid soap and warm running water or use alcohol hand rub.

Waste disposal

  • Educate people and carers about the correct handling, storage, and disposal of healthcare waste.
  • Healthcare waste must be: 
    • Handled correctly.
      • Wear appropriate personal protective equipment when handling waste.
      • Hold waste bags by the neck and keep them at arm's length to reduce the risk of injury in case a sharp item has been inappropriately disposed of in the bag.
      • Never open a clinical waste bag to examine the contents.
      • Liquid waste; for example, suction canisters, should be rendered safe through the addition of a polymer gel or compound to the container, prior to its placement in a leak-proof orange-lidded bin, or leak-proof yellow-lidded bin if contaminated by pharmaceuticals.
    • Segregated correctly immediately by the person generating the waste into appropriate colour-coded storage or waste disposal bags or containers that are compliant with current national legislation and local policies. 
      • Orange — infectious waste (for example contaminated gloves or dressings).
      • Yellow and black striped — offensive/hygiene waste (for example, stoma or catheter bags).
      • Purple — cytotoxic or cytostatic medicine waste (for example, cytotoxic or cytostatic medicine containers with residue).
      • Blue — medicinal waste (for example, expired non-cytotoxic or -cytostatic medicines).
      • Black — domestic waste (for example, paper towels and food waste).
    • Labelled appropriately with the address and date prior to collection by the waste contractor (some waste contractors may undertake this) to ensure traceability if an incident occurs. 
    • Packaged for transportation — waste bags should be no more than 2/3 full. This allows enough space for the bag to be tied using a suitable plastic zip tie or secure knot.
      • If a waste bag awaiting collection is torn, the torn bag and contents should be placed inside a new waste bag.
    • Stored safely in a secure place away from public access. 
    • Transported and disposed of in accordance with current national legislation and local policies. 
    • For safe disposal of sharps, see the section on the Safe use and disposal of sharps.

Blood and body fluid spillage

  • Spillages of blood and other body fluids may transmit blood-borne viruses. 
  • Appropriate PPE should be worn when treating blood or body fluid spillages.
  • Spillages should be treated immediately by staff trained to do so safely. 
    • Apply chlorine-releasing granules or an appropriate spill kit when dealing with blood or body fluid, following the manufacturer’s instructions.
    • Dispose of the spillage and contents of the pack as infectious waste.
    • If the spill occurs on soft furnishings such as carpets, discuss with the infection prevention and control team.
      • Consider if the furnishings can withstand a chlorine-releasing solution or whether it is safe to clean with detergent alone. If this is not the case, or the furnishings are heavily contaminated, they should be discarded.
  • Deal with spillages containing only urine, faeces, vomit, and/or sputum appropriately.
    • Soak up the spillage with disposable paper towels, a gelling agent may be used on urine spillages.
    • Decontaminate the area using a solution of 1000 parts per million available chlorine solution or 1000 parts per million available chlorine detergent/chlorine releasing solution, following the manufacturer's instructions.
      • Do not place a chlorine-based product directly on urine as toxic fumes are released.
  • Once the area has been treated, wash the area with disposable paper towels and a solution of general-purpose detergent and warm water, dry the area or allow it to air dry, and perform hand hygiene.

Laundry

  • Use disposable paper products (for example, paper towels and couch roll).
    • Do not use linen such as blankets, pillowcases, or fabric hand towels — it is not practical to launder items between each consultation.
  • Use fabric curtains and screens — these should be laundered by a professional laundry service on a documented planned schedule (for example, 6-monthly or laundered immediately if visibly soiled). 
    • Change disposable curtains, if used, every 6 months or immediately if visibly soiled. The date the curtain is put up should be documented.
  • Seal pillows and blankets in a wipeable cover with no tears and clean with a detergent wipe after use.
    • Disposable couch roll should be used to cover the pillow or maintain the patient’s modesty for procedures where this is required and disposed of after use.
  • Wear personal protective equipment (for example, a disposable apron) to prevent contamination of uniform and workwear.
  • Ensure uniforms and workwear are:
    • Fit for purpose and support good hand hygiene.
    • Changed immediately if it becomes visibly soiled or contaminated.
    • Laundered separately from other clothing on a hot wash cycle at the highest temperature that the fabric will tolerate.
      • Garments should be dried thoroughly. Tumble drying or ironing will further reduce the small number of microorganisms present after washing.
  • Neckties and lanyards may become contaminated by pathogens, can accidentally come into contact with people, and are rarely laundered. Therefore, it is recommended that they are not worn whilst undertaking direct care activities. 

Decontamination of equipment

  • Decontaminate all reusable equipment after use — the method used depends on the manufacturer’s instructions, a risk assessment of the procedure, and the item being used in accordance with Control of Substances Hazardous to Health (COSHH) Regulations.
    • Some equipment will have specific instructions which should be followed (for example, Propulse machine or peak flow meters).
  • Decontamination should occur:
    • Between each patient use.
    • After blood or body fluid contamination.
    • Before inspection, servicing, repair, being loaned out, decommissioning, recycling, and disposal.
    • At regular, pre-defined intervals as part of a cleaning schedule. 
    • After visible soiling or contamination.
  • There are three levels of decontamination: 
    • Cleaning — physically removes infectious agents and organic matter, but does not necessarily destroy infectious agents.
      • Clean, non-invasive, reusable equipment before disinfection or sterilisation is carried out.
      • Use detergent wipes, or a neutral detergent with warm water and single-use cloths.
      • Dry all equipment that has been cleaned thoroughly before storage.
    • Disinfection — reduces the number of viable microorganisms but may not necessarily inactivate some infectious agents. Disinfect any non-invasive, reusable equipment, following the manufacturer's instructions:
      • That has been contaminated with blood or body fluid.
      • That has come into contact with mucous membranes.
      • That is contaminated with particularly virulent or readily transmitted organisms.
      • Before use on an immunocompromised person.
    • Sterilisation — destroys all microorganisms including spores. Re-usable items requiring sterilisation must be sent to an accredited decontamination services facility.
  • Ensure the correct amount of disinfectant and water are used — if a chlorine-based solution is used it should be at a dilution of 1000 ppm.
    • As diluted chlorine-based disinfectant solutions are unstable and become less effective after 24 hours, a new solution should be made each day.
  • Always wear disposable gloves, an apron, and eye protection if indicated. 

Environmental cleanliness

  • The care environment must be:
    • Visibly clean and free of non-essential items and equipment to aid in effective cleaning.
    • Well maintained, in a good state of repair, and with effective ventilation.
    • Routinely cleaned following the national cleaning standards.
  • Ensure a cleaning plan is in place — this should include: 
    • The standards to be achieved.
    • Clear allocation of responsibility for cleaning of all areas and items and a designated person to lead on cleaning and decontamination.
    • Cleaning schedules and frequencies and the names of people responsible for cleaning.
    • Systems to measure outcomes, the reports required and who should receive them.
    • Operational and training policies and procedures and risk assessment protocols.
    • How cleaning services, operations and controls dovetail with arrangements for infection control, including training for all cleaning staff in infection control policies and procedures.
    • A documented record of cleaning undertaken.
    • The management arrangements in place to ensure external cleaning contractors (if used) deliver against the contract.
      • Suitable arrangements should be in place to monitor standards of cleaning and to deal with poor or unsatisfactory performance.
  • Ensure blood and body fluid spillages are dealt with promptly. 
  • Limit the number of cleaning products to avoid inappropriate use.
    • Detergents — warm water and neutral detergent or detergent wipes are suitable for many cleaning activities.
      • Select and use a good quality neutral detergent or detergent wipe.
      • Liquid detergents classed as anionic and non-ionic have the best detergent activity.
    • Disinfectants — these are not required for routine cleaning. 
      • Use spillage kits for disinfecting surfaces following a blood or body fluid spillage. 
      • Use disinfectants that are virucidal and bactericidal for disinfecting surfaces after dealing with a person with a known infection. 
      • Alcohol wipes can be used, but as they do not contain a cleaning agent, surfaces should first be wiped with a detergent wipe or solution of neutral detergent and warm water. Alcohol is effective against meticillin-resistant Staphylococcus aureus (MRSA) and multi-resistant gram negative bacteria (MRGNB), but is not effective against Norovirus or Clostridioides difficile.
      • Make up disinfectant solutions according to the manufacturer’s instructions.
  • Use colour coding for cleaning equipment used for cleaning different areas — this ensures that these items are not used in multiple areas, therefore, reducing the risk of transmission of infection from one area to another, (for example, toilet to kitchen).
    • Yellow — treatment and minor operation rooms.
    • Green — kitchens.
    • Blue — general areas (for example, waiting rooms and consulting rooms, including sinks in general areas).
    • Red — sanitary areas, including sinks in sanitary areas.
  • Measures for reducing the risk of transmission of infection from cleaning equipment include: 
    • Use single-use cloths.
    • Store equipment clean and dry after use in a designated area.
    • Store products in a designated lockable area.
    • Wash mop heads in the bucket in detergent and warm water after use, rinse and store upright to dry. Replace mop heads regularly depending on the frequency of use, or if visably stained.
      • Do not store equipment, (for example, mops) overnight in disinfectants or disinfectant solutions. If disinfection is required, wash the mop head in detergent and warm water, rinses and soak for 30 minutes in a hypochlorite solution at 1,000 ppm, rinse and then store upright to dry.
    • Floor scrubbing machines, steam cleaners, and carpet shampoo machines, should be designed to enable tanks to be emptied, cleaned, and dried.
    • Ensure each toilet has its own toilet brush and holder.
      • Place the toilet brush head beneath the water level and flush the toilet, and clean thoroughly after use.
  • Measures for reducing the risk of transmission of infection from furniture, fixtures, fittings, and toys include ensuring that: 
    • Surfaces are smooth, wipeable, and non-impervious to facilitate effective cleaning.
    • Damaged surfaces are repaired or replaced. 
    • 1000 ppm available chlorine is used routinely on sanitary fittings.
    • When purchasing new furniture, fixtures, and fittings the item can be easily cleaned.
    • Toys are wipeable and in good condition, and they are cleaned regularly (for example, weekly, with detergent and warm water) and included in the cleaning schedule.
      • Note: magazines are allowed in waiting rooms.

Respiratory and cough hygiene

  • To minimise the risk of cross-contamination from respiratory illness: 
    • Cover the nose and mouth with a disposable tissue when sneezing, coughing, wiping and blowing the nose.
    • Dispose of all used tissues promptly into a waste bin.
    • Wash hands with non-antimicrobial liquid soap and warm water after coughing, sneezing, using tissues, or after contact with respiratory secretions or objects contaminated by these secretions.
    • Where there is no running water available or hand hygiene facilities are lacking, use hand wipes followed by alcohol-based hand rub and wash hands as soon as possible. 
    • Keep contaminated hands away from the eyes nose and mouth.
  • Staff should promote respiratory and cough hygiene helping those (eg, elderly, children) who need assistance with this, eg providing patients with tissues, a dedicated receptacle i.e. waste bag for used tissues and hand hygiene facilities as necessary.

Basis for recommendation

These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidance Healthcare-associated infections: prevention and control in primary and community care [NICE, 2017], the NHS England National infection prevention and control manual (NIPCM) for England [NHS England, 2024], the NHS National Services Scotland (NHS NSS) National Infection Prevention and Control Manual [NHS NSS, 2024], and Infection Prevention and Control policies for general practice Safe management of the care environment [IPC, 2023d], Safe management of linen, including uniforms and workwear [IPC, 2023e], Venepuncture [IPC, 2023f], Safe disposal of waste, including sharps [IPC, 2023g], Safe management of sharps and inoculation injuries [IPC, 2023h], Safe management of care equipment [IPC, 2023i], and Hand hygiene [IPC, 2023j].

What general precautions should be taken when using invasive devices?

  • An invasive device is a device which, in whole or part, penetrates inside the body, either through an orifice or through the surface of the body.
    • A surgically invasive device penetrates inside the body through the surface during a surgical operation or procedure.
  • Invasive devices include: 
  • Prior to insertion, the need for any invasive device should be evaluated, and any alternative methods should be considered.
  • When inserting a device:
    • Ensure only staff trained and competent in the insertion of the type of device perform the procedure.
    • Ensure the insertion takes place in a clinical environment (for example, a treatment room).
    • Ensure all equipment used for the procedure is sterile, the packaging is intact and the equipment is within the expiry date.
    • Perform appropriate skin decontamination prior to inserting a device through the skin (for example, using 2% Chlorhexidine in 70% alcohol).
      • Apply standard precautions and aseptic technique during the insertion of the device.
    • Record details of the device, the reason for insertion and the date inserted in the person's notes.
  • When managing an invasive device:
    • Review the need for an invasive device regularly and remove it as soon as possible.
    • The principles of care for any invasive device are to:
      • Prevent infection.
      • Maintain a ‘closed’ system with as few connections as possible to reduce the risk of contamination.
      • Keep the device patent.
      • Prevent damage to the device and any attachments.
      • Apply standard precautions and aseptic techniques when manipulating the device.
      • Record any signs or symptoms of infection associated with the device and any action taken.
      • Seek further appropriate advice as required (for example, from a consultant microbiologist).

What precautions are needed for long-term urinary catheters?

  • In addition to the general precautions for people with invasive devices, specific precautions for people with urinary catheters include: 
    • Use aseptic procedure for all catheterisations.
    • When changing catheters in people with a long-term indwelling urinary catheter:
      • Do not offer antibiotic prophylaxis routinely.
      • Consider antibiotic prophylaxis for people who have a history of symptomatic urinary tract infection after catheter change or experience trauma during catheterisation.
  • Maintenance precautions include:
    • Ensure the catheter is connected to a sterile closed urinary drainage system or catheter valve.
    • Decontaminate hands and wear a new pair of clean, non-sterile gloves before manipulating a catheter, and decontaminate hands after removing gloves. 
    • Educate people managing their own catheters, and their carers about the need for hand decontamination before and after manipulation of the catheter.  
    • Advise men to wash the meatus daily with soap and water.
  • To minimise the risk of blockages, encrustations, and catheter-associated infections:
    • Develop a patient-specific care regimen.
    • Consider approaches such as reviewing the frequency of planned catheter changes and increasing fluid intake.
    • Document catheter blockages.
  • Other precautions include: 
    • Obtain urine samples from a sampling port using an aseptic technique (if/when required). 
    • Position urinary drainage bags below the level of the bladder, but not in contact with the floor. 
    • Use a link system to facilitate overnight drainage, to keep the original system intact. 
    • Empty the urinary drainage bag frequently enough to maintain urine flow and prevent reflux, and changed it when clinically indicated. 
  • Do not use bladder instillations or washouts to prevent catheter-associated infections.

What precautions are needed for enteral feeding devices?

  • Use pre-packaged, ready-to-use feeds whenever possible in preference to feeds which require decanting, reconstitution or dilution. 
    • The chosen system should require minimal handling to assemble, and be compatible with the patient's enteral feeding tube.
  • Ensure effective hand decontamination before starting feed preparation. 
  • When preparing feeds: 
    • Use a clean working area and only use equipment dedicated for enteral feed use.
    • Mix feeds using cooled boiled water or freshly opened sterile water and a no-touch technique.
  • When administering feeds:  
    • Use minimal handling and an aseptic technique to connect the administration system to the enteral feeding tube. 
    • Use administration sets and feed containers once and discard after each feeding session.
  • Store feeds according to the manufacturer's instructions and, where applicable, food hygiene legislation — if ready-to-use feeds are not available, feeds may be prepared in advance, stored in a refrigerator, and used within 24 hours. 
  • Maintain the insertion site and enteral feeding tube:
    • Wash the stoma daily with water and dry thoroughly. 
    • Flush the enteral feeding tube before and after feeding or administering medications using single-use syringes or single-patient-use (reusable) syringes according to the manufacturer's instructions to prevent blockages. Use:
      • Freshly drawn tap water for people who are not immunosuppressed.
      • Cooled freshly boiled water or sterile water from a freshly opened container for people who are immunosuppressed. 

What precautions are needed for vascular access devices?

  • Decontaminate the skin at the insertion site with chlorhexidine gluconate in 70% alcohol before inserting a peripheral vascular access device. 
    • Use a sterile transparent semipermeable membrane dressing to cover the insertion site. 
      • Replace the dressing covering central venous access devices insertion site every 7 days, or sooner if the dressing is no longer intact or moisture collects under it. 
      • Leave the dressing applied to a peripheral cannula insertion site in situ for the life of the cannula, provided that the integrity of the dressing is retained. 
      • Replace dressings on tunnelled or implanted central venous catheter sites every 7 days until the insertion site has healed unless there is an indication to change them sooner. 
    • Consider a sterile gauze dressing covered with a sterile transparent semipermeable membrane dressing only if the patient has profuse perspiration or if the vascular access device insertion site is bleeding or oozing. If a gauze dressing is used:
      • Change it every 24 hours, or sooner if it is soiled.
      • Replace it with a sterile transparent semipermeable membrane dressing as soon as possible. 
    • Ensure that catheter-site care is compatible with catheter materials (tubing, hubs, injection ports, luer connectors and extensions) and check compatibility with the manufacturer's recommendations. 
  • Decontaminate the central venous catheter insertion site and surrounding skin during dressing changes using chlorhexidine gluconate in 70% alcohol, and allow to air dry.
    • Consider using an aqueous solution of chlorhexidine gluconate if the manufacturer's recommendations prohibit the use of alcohol with the catheter.
    • Use individual sachets of antiseptic solution or individual packages of antiseptic-impregnated swabs or wipes.
  • The general principles for management of vascular access devices include: 
    • Decontaminate hands before accessing or dressing a vascular access device, and use an aseptic technique when accessing the system.
    • Decontaminate the injection port or vascular access device catheter hub before and after accessing the system using chlorhexidine gluconate in 70% alcohol.
      • Consider using an aqueous solution of chlorhexidine gluconate if the manufacturer's recommendations prohibit the use of alcohol with the catheter.
    • Preferably, use: 
      • A single lumen catheter to administer parenteral nutrition. If a multilumen catheter is used, one port must be exclusively dedicated for total parenteral nutrition, and all lumens must be handled with the same attention to aseptic technique. 
      • A sterile 0.9 percent sodium chloride injection to flush and lock catheter lumens. When recommended by the manufacturer, implanted ports or opened-ended catheter lumens should be flushed and locked with heparin sodium flush solutions. 
    • Do not routinely use: 
      • In-line filters for infection prevention. 
      • Antibiotic lock solutions, or systemic anticoagulants to prevent catheter-related bloodstream infections (CRBSI). 
      • Systemic antimicrobial prophylaxis to prevent catheter colonisation or CRBSI during the use of a central venous catheter. 
    • If needleless devices are used:
      • Follow the manufacturer's recommendations for changing the needleless components.
      • Ensure that all components of the system are compatible and secured, to minimise leaks and breaks in the system. 
      • Minimise the risk of contamination by decontaminating the access port with either alcohol or an alcoholic solution of chlorhexidine gluconate before and after using it to access the system.
    • In general, administration sets in continuous use do not need not be replaced more frequently than at 72-hour intervals unless they become disconnected or a catheter-related infection is suspected or documented. Replace administration sets for: 
      • Blood and blood components every 12 hours, or according to the manufacturer's recommendations. 
      • Parenteral nutrition infusions every 24 hours — if the solution contains only glucose and amino acids, administration sets in continuous use do not need to be replaced more frequently than every 72 hours. 
    • Avoid the use of multidose vials, in order to prevent the contamination of infusates. 

Basis for recommendation

These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidance Healthcare-associated infections: prevention and control in primary and community care [NICE, 2017] and the Infection Prevention Control policy for general practice invasive devices [IPC, 2023k]. 

What precautions should be taken for specific infections?

  • In addition to standard precautions, transmission-based precautions (TBPs) may be necessary, depending on the: 
    • Suspected/known infectious agent.
    • Severity of the illness caused.
    • Transmission route of the infectious agent.
    • Care setting and procedures undertaken.
  • TBPs are categorised by the route of transmission (some infections can be transmitted by more than one route). 
    • Contact — used to prevent and control infections that spread via direct contact with the person or indirectly from their immediate care environment (including care equipment). This is the most common route of cross-infection transmission.
    • Droplet — used to prevent and control infections spread over short distances (at least 1 metre) via droplets from the respiratory tract of one person onto a mucosal surface or conjunctivae of another. Droplets penetrate the respiratory system to above the alveolar level.
    • Airborne — used to prevent and control infections spread without necessarily having close patient contact via aerosols from the respiratory tract of person onto a mucosal surface or conjunctivae of another. Aerosols penetrate the respiratory system to the alveolar level.

Table 2. Transmission based precautions (TBPs) required for infectious agents.

Suspected or confirmed pathogenDiseaseType of TBP required
AdenovirusUpper/lower respiratory tract infectionDroplet
AdenovirusConjunctivitis, gastroenteritisContact
Bordetella pertussisWhooping coughDroplet
Clostridioides difficileClostridioides difficile infectionContact
Coronavirus (seasonal) including SARS-CoV-2Respiratory symptoms including asymptomatic presentations, COVID-19Droplet/airborne
Hepatitis AHepatitis, gastroenteritisContact
Herpes zosterShingles (vesicle sack)Contact
Influenza virusInfluenzaDroplet
Measles virusMeaslesDroplet/airborne

Meticillin-resistant Staphylococcus aureus (MRSA)

Colonisation, skin and wound infections, endocarditis, pneumonia, osteomyelitis, urinary tract infections, and bacteraemia

Contact
Mumps virusMumpsDroplet
NorovirusWinter vomiting diseaseContact

Panton-Valentine Leukocidin Staphylococcus aureus (PVL-SA)

Skin and soft tissues infection, necrotising pneumonia, necrotising fasciitis, osteomyelitis, septic arthritis and pyomyositis, purpura fulminans

Contact
Salmonella sppGastroenteritisContact
Source: [NHS England, 2024]

Blood-borne viruses

  • Blood borne-viruses (BBVs) include: 
    • Human immunodeficiency virus (HIV), which causes acquired immune deficiency syndrome (AIDS). For more information, see the CKS topic on HIV infection and AIDS. 
    • Hepatitis B virus (HBV). For more information, see the CKS topic on Hepatitis B. 
    • Hepatitis C virus (HCV). For more information, see the CKS topic on Hepatitis C. 
  • Precautions to prevent inoculation with BBVs include:
    • Standard precautions — used appropriately these should be sufficient to ensure that no extra precautions are required for people known to carry these viruses.
      • Blood and body fluid spillage — urine, faeces, sputum, tears, sweat and vomit are not considered to pose a risk unless they are contaminated with blood. 
      • Waste disposal. 
      • Venepuncture and sharps disposal — specimens and request forms from people known to be or suspected of being infected with blood-borne viruses should be labelled with a ‘Danger of Infection’ or ‘hazard’ sticker.
    • Use of safety sharps where appropriate.
    • Appropriate management of percutaneous exposures (sharps/splash injuries).
    • Protection of clinical and other staff with hepatitis B vaccination.
  • Standard infection prevention and control precautions for reducing the risk of transmission of BBVs include:
    • Keep cuts or broken skin covered with waterproof dressings.
    • Protect eyes, mouth and nose from blood splashes where there is a risk of splashing.
    • Avoid direct skin contact with blood and blood-stained body fluids
      • If blood/blood-stained body fluids are splashed on the skin, wash off with liquid soap and warm running water.
    • Wear disposable latex/nitrile gloves when contact with blood or body fluids is likely.
    • Always clean hands after removing gloves.
    • Always clean hands before and after giving first aid.
    • Contain and promptly disinfect surfaces contaminated by spillages of blood and body fluids.

Clostridioides difficile

  • Follow standard procedures, including. 
    • Hand hygiene — use liquid soap and warm running water.
      • Do not use alcohol hand rubs as these do not kill spores.
    • Personal protective equipment — wear disposable gloves and an apron.
      • Remove these (gloves first then apron) and dispose of them appropriately. If in the person's home, use the household waste and wash hands thoroughly.
    • Environmental cleanliness — C. difficile spores can survive in the environment for years if not properly cleaned. If a person with confirmed C. difficle infection has been in the practice within 48 hours of having diarrhoea, the immediate environment must be decontaminated using a 1000 ppm chlorine-based disinfectant solution or 2 in 1 detergent and chlorine based disinfectant solution.  
  • Advise symptomatic people to:
    • Wash hands thoroughly with liquid soap and warm running water, especially after going to the toilet and before preparing or eating food.
    • Use a separate towel to dry hands and to wash it daily.
      • This should not be used by other members of the household or visitors.
    • Close the toilet seat lid before flushing after an episode of diarrhoea — this will reduce spread onto surrounding surfaces.
    • Clean hard surfaces in toilets/bathrooms (for example, taps, toilet flush, door handles, soap dispenser) at least daily using household bleach. 
    • Wash soiled clothing and bedding as soon as possible — these should be washed separately from other people’s laundry at the highest temperature the fabric will tolerate.
    • Have a shower or bath every day if possible, as C. difficile can be present on other areas of the body.
    • Stay at home until free from diarrhoea for 48 hours to prevent spreading it to other people, if possible.
    • Drink plenty of fluids to prevent dehydration.
  • Also advise them:
    • Not to take medicines to stop diarrhoea (unless prescribed by a healthcare professional), as this will stop C. difficile being cleared from the body. 
    • That visitors, including pregnant women and children, are not at risk if they are healthy.
    • That once recovered, there is no risk to other people.
    • If they been given a C. difficile card to show it to healthcare professionals.
  • See the CKS topic Diarrhoea - antibiotic associated for more information.

Creutzfeldt-Jakob disease

  • No special measures over and above standard infection control procedures are required when caring for people with CJD or vCJD, as it is unlikely that a procedure will be undertaken that involves contact with high or medium risk tissues.

Multi-resistant gram negative bacteria (MRGNB)

  • Follow standard infection control precautions and good hand hygiene practice. 
    • Hand hygiene is essential before and after direct contact — use liquid soap and warm running water or alcohol hand rub.
  • No specific precautions are required for people attending for a routine GP consultation, however, personal protective equipment should be worn if an examination is undertaken involving contact with body fluids.
    • Schedule people attending for a procedure (for example, wound dressing) at the end of the session to allow for environmental cleaning, if possible.
    • Wear disposable gloves and apron when in contact with body fluids  — dispose of these after each procedure.
    • Wear long sleeved fluid-repellent gowns, if there is a risk of extensive splashing of body fluids to the uniform.
    • Clean the treatment couch and immediate area with detergent and warm water followed by a hypochlorite solution at a dilution of 1000 ppm, e.g. Haz tabs, Presept or a disinfectant wipe if the person has attended for a procedure.
    • Dispose of waste contaminated with body fluids as infectious waste.

Meticillin-resistant Staphylococcus aureus

  • Follow standard infection control precautions and good hand hygiene practice. 
    • Hand hygiene is essential before and after direct contact — use liquid soap and warm running water or alcohol hand rub.
  • No specific precautions are required for people attending for a routine GP consultation, however, personal protective equipment should be worn if an examination is undertaken involving contact with body fluids.
    • Schedule people attending for a procedure (for example, wound dressing) at the end of the session to allow for environmental cleaning, if possible.
    • Wear disposable gloves and apron when in contact with body fluids  — dispose of these after each procedure.
    • Wear long sleeved fluid repellent gowns if there is a risk of extensive splashing of body fluids to the uniform.
    • Clean the treatment couch and immediate area with detergent and warm water followed by a hypochlorite solution at a dilution of 1000 ppm, e.g. Haz tabs, Presept or a disinfectant wipe if the person has attended for a procedure.
    • Dispose of waste contaminated with body fluids as infectious waste.

Norovirus

  • Follow standard infection control precautions and good hand hygiene practice. 
  • When assessing people with suspected norovirus:
    • Wash hands with liquid soap and warm running water and dry with paper towels.
      • Alcohol hand rub should not be used as it is not effective at killing norovirus.
    • Wear a disposable apron and gloves.
    • Wash hands again after removing the apron and gloves. 
  • Encourage people with symptoms to wash their hands thoroughly with liquid soap and warm running water:
    • After an episode of vomiting or diarrhoea,
    • After using the toilet.
    • Before eating and drinking.
  • During periods of increased activity with norovirus: 
    • Remind practice staff to wash their hands thoroughly (rather than using alcohol hand rub) after patient contact, before their breaks and before eating and drinking.
  • Advise people (including staff) with vomiting and/or diarrhoea to stay off work until they are symptom-free for 48 hours. 
    • If this occurs at work, send staff home immediately.
  • If a person vomits, clear up spillages promptly:
    • Wear personal protective equipment (for example, apron and gloves).
    • Ventilate the area by opening doors and windows, if possible.
    • Use an appropriate body fluid spillage kit to clean the affected area.
      • Do not use a chlorine-based disinfectant in a carpeted area, clean with detergent and warm water, a carpet cleaning machine or steam cleaner.
    • Dispose of waste and personal protective equipment as infectious waste.
    • Wash hands with liquid soap and warm running water.
    • If a mop and bucket are used, they should be in accordance with the national colour coding.
      • After use, the mop head should be disposed of immediately as infectious waste and the bucket washed with detergent and warm water and then wiped with a chlorine-based disinfectant at 1,000 parts per million and stored upside down.
    • All cloths used must be single use and disposed of after use.

Panton-Valentine Leukocidin staphylococcus aureus (PVL-SA)

  • Discuss a confirmed diagnosis of PVL-SA with the local Community Infection Prevention and Control (IPC) or Public Health England (PHE) team.
  • Follow standard infection control precautions and good hand hygiene practice. 
    • Hand hygiene is essential before and after direct contact — use liquid soap and warm running water or alcohol hand rub.
  • No specific precautions are required for people attending for a routine GP consultation, however, personal protective equipment should be worn if an examination is undertaken involving contact with body fluids.
    • Schedule people attending for a procedure (for example, wound dressing) at the end of the session to allow for environmental cleaning, if possible.
    • Wear disposable gloves and apron when in contact with body fluids  — dispose of these after each procedure.
    • Wear long sleeved fluid repellent gowns if there is a risk of extensive splashing of body fluids to the uniform.
    • Disinfect the treatment couch, surfaces, immediate area, and any medical devices used if the person has attended for a procedure. Use a dual acting product — for example, Chlor-Clean, Actichlor plus, made into a solution at a concentration of 1,000 parts per million (ppm), or a wipe, such as Clinell Universal.
    • Dispose of waste contaminated with body fluids as infectious waste.

Basis for recommendation

These recommendations are based on the NHS National Services Scotland (NHS NSS) National Infection Prevention and Control Manual [NHS NSS, 2024], and the Infection Prevention and Control policies for general practice Blood-borne viruses [IPC, 2023l], C. difficile (Clostridioides difficile) [IPC, 2023c], CJD (Creutzfeldt-Jakob disease) [IPC, 2023m], MRGNB including CPE [IPC, 2023n], MRSA [IPC, 2023a], and Viral gastroenteritis/ norovirus [IPC, 2023o], and PVL-SA [IPC, 2023b].

Transmission routes

The COVID-19 pandemic highlighted that the traditional method of describing respiratory transmission routes (droplet or airborne) may not be reflective of what happens in real life, and is likely to change. The application of TBPs may differ depending on the setting and the known or suspected infectious agent [NHS England, 2024; NHS NSS, 2024].

Supporting evidence

This CKS topic is largely based on the National Institute for Health and Care Excellence (NICE) guidance Healthcare-associated infections: prevention and control in primary and community care [NICE, 2017], the NHS National Services Scotland (NHS NSS) National Infection Prevention and Control Manual [NHS NSS, 2024], and the NHS England National infection prevention and control manual (NIPCM) for England [NHS England, 2024].

How this topic was developed

This section briefly describes the processes used in developing and updating this topic. Further details on the full process can be found in the About Us section and on the Clarity Informatics website.

Search strategy

A literature search was conducted for guidelines and systematic reviews on primary care management of healthcare-associated infections.

Search dates

April 2019 - June 2024

Key search terms

The terms listed below are the core search terms that were used for EBSCOhost MEDLINE (searched 3rd December 2018). These were combined with filters to identify guidelines, systematic reviews and primary care relevant literature in EBSCOhost MEDLINE. The strategy was adapted for The Cochrane Library databases. 

S6    S1 OR S2 OR S3 OR S4 OR S5 
S5    TI infection prevention or infection control 
S4    (MH "Infection Control+") 
S3    AB nosocomial infection* OR TI nosocomial infection* 
S2    TI ( healthcare associated infection* or health-care associated infection* or healthcare-associated infection* or HCAI ) OR AB ( healthcare associated infection* or health-care associated infection* or healthcare-associated infection* or HCAI ) 
S1    (MH "Cross Infection+") 

Sources of guidelines

Sources of systematic reviews and meta-analyses

  • The Cochrane Library:
    • Systematic reviews
    • Protocols
    • Database of Abstracts of Reviews of Effects
  • Medline (with systematic review filter)
  • EMBASE (with systematic review filter)

Sources of health technology assessments and economic appraisals

Sources of randomized controlled trials

  • The Cochrane Library:
    • Central Register of Controlled Trials
  • Medline (with randomized controlled trial filter)
  • EMBASE (with randomized controlled trial filter)

Sources of evidence based reviews and evidence summaries

Sources of national policy

Patient experiences

Sources of medicines information

The following sources are used by CKS pharmacists and are not necessarily searched by CKS information specialists for all topics. Some of these resources are not freely available and require subscriptions to access content.

Stakeholder engagement

Our policy

The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:

  • Clinical accuracy.
  • Consistency with other providers of clinical knowledge for primary care.
  • Accuracy of implementation of national guidance (in particular NICE guidelines).
  • Usability.

Principles of the consultation process

  • The process is inclusive and any individual may participate.
  • To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.
  • Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.
  • Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.
  • External reviewers are not paid for commenting on the draft topics.
  • Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).
  • All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.
  • All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.

Stakeholders

  • Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the Getting involved section of the Clarity Informatics website.
  • Stakeholders identified from the following groups are invited to review draft topics:
    • Experts in the topic area.
    • Professional organizations and societies (for example, Royal Colleges).
    • Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.
    • Guideline development groups where the topic is an implementation of a guideline.
    • The British National Formulary team.
    • The editorial team that develop MeReC Publications.
  • Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.

Patient engagement

Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:

  • Topic selection
  • Scoping of topic
  • Selection of clinical scenarios
  • First draft internal review
  • Second draft internal review
  • External review
  • Final draft and pre-publication

Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.

Evidence exclusion criteria

Our policy

Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.

Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.

Standard exclusions for scoping literature:

  • Animal studies
  • Original research is not written in English

Possible exclusions for reviewed literature:

  • Sample size too small or study underpowered
  • Bias evident or promotional literature
  • Population not relevant
  • Intervention/treatment not relevant
  • Outcomes not relevant
  • Outcomes have no clear evidence of clinical effectiveness
  • Setting not relevant
  • Not relevant to UK
  • Incorrect study type
  • Review article
  • Duplicate reference

Organizational, behavioural and financial barriers

Our policy

The CKS literature searches take into consideration the following concepts, which are discussed at the initial scoping of the topic.

  • Feasibility
    • Studies are selected depending on whether the intervention under investigation is available in the NHS and can be practically and safely undertaken in primary care.
  • Organizational and Financial Impact Analysis
  • Studies are selected and evaluated on whether the intervention under investigations may have an impact on local clinical service provision or national impact on cost for the NHS. The principles of clinical budget impact analysis are adhered to, evaluated and recorded by the author. The following factors are considered when making this assessment and analysis.
    • Eligible population
    • Current interventions
    • Likely uptake of new intervention or recommendation
    • Cost of the current or new intervention mix
    • Impact on other costs
    • Condition-related costs
    • In-direct costs and service impacts
    • Time dependencies
  • Cost-effectiveness or cost-benefit analysis studies are identified where available. 

We also evaluate and include evidence from NICE accredited sources which provide economic evaluations of recommendations, such as NICE guidelines. When a recommended action may not be possible because of resource constraints, this is explicitly indicated to healthcare professionals by the wording of the CKS recommendation.

Declarations of interest

Our policy

Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the Clarity Informatics website. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:

  • Personal financial interests
  • Personal family interest
  • Personal non-financial interest
  • Non-personal financial gain or benefit

Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.

Who should declare competing interests?

Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.

Competing interests declared for this topic:

None.

References

Change privacy settings